BGIM
BMY.RT
Boussard & Gavaudan Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-492,449
| Closed | -$596K | – | 113 |
|
|
2020
Q4 | $596K | Sell |
492,449
-34,232
| -6% | -$41.4K | 0.08% | 46 |
|
|
2020
Q3 | $1.07M | Buy |
526,681
+109,888
| +26% | +$224K | 0.14% | 37 |
|
|
2020
Q2 | $1.42K | Buy |
416,793
+10,984
| +3% | +$37 | 0.27% | 26 |
|
|
2020
Q1 | $1.58M | Buy |
405,809
+179,689
| +79% | +$701K | 0.34% | 24 |
|
|
2019
Q4 | $690K | Buy |
+226,120
| New | +$690K | 0.15% | 22 |
|